Association between sigma-1 receptor gene polymorphism and prefrontal hemodynamic response induced by cognitive activation in schizophrenia
暂无分享,去创建一个
Masato Fukuda | Kiyoto Kasai | Yuki Kawakubo | Kenji Hashimoto | Ryu Takizawa | Kohei Marumo | Tsukasa Sasaki | Mamoru Tochigi | K. Hashimoto | K. Kasai | Y. Kawakubo | M. Tochigi | R. Takizawa | M. Fukuda | Tsukasa Sasaki | Kohei Marumo
[1] Z. Vogel,et al. Sigma receptor ligands modulate contractility, Ca++ influx and beating rate in cultured cardiac myocytes. , 1994, The Journal of pharmacology and experimental therapeutics.
[2] Makoto Ito,et al. Multichannel near-infrared spectroscopy in depression and schizophrenia: cognitive brain activation study , 2004, Biological Psychiatry.
[3] Archana K. Singh,et al. Exploring the false discovery rate in multichannel NIRS , 2006, NeuroImage.
[4] M. Tamura,et al. Interpretation of near-infrared spectroscopy signals: a study with a newly developed perfused rat brain model. , 2001, Journal of applied physiology.
[5] Andreas Meyer-Lindenberg,et al. False positives in imaging genetics , 2008, NeuroImage.
[6] R. C. Oldfield. The assessment and analysis of handedness: the Edinburgh inventory. , 1971, Neuropsychologia.
[7] Teruo Hayashi,et al. Regulating ankyrin dynamics: Roles of sigma-1 receptors. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] R. Cabeza,et al. Imaging Cognition II: An Empirical Review of 275 PET and fMRI Studies , 2000, Journal of Cognitive Neuroscience.
[9] S. Higuchi,et al. Functional polymorphisms in the sigma1 receptor gene associated with alcoholism , 2003, Biological Psychiatry.
[10] M. Itokawa,et al. Association between polymorphisms in the type 1 sigma receptor gene and schizophrenia , 1998, Neuroscience Letters.
[11] D. Boas,et al. Non-invasive neuroimaging using near-infrared light , 2002, Biological Psychiatry.
[12] Masato Fukuda,et al. Reduced frontopolar activation during verbal fluency task in schizophrenia: A multi-channel near-infrared spectroscopy study , 2008, Schizophrenia Research.
[13] L. Clare,et al. A Meta-Analysis of Cognitive Deficits in Adults with a Diagnosis of Schizophrenia , 2005, Neuropsychology Review.
[14] C. Montigny,et al. N-methyl-D-aspartate-induced neuronal activation is selectively modulated by σ receptors , 1990 .
[15] A. Privat,et al. The anti-amnesic effects of sigma1 (σ 1) receptor agonists confirmed by in vivo antisense strategy in the mouse , 2001, Brain Research.
[16] Y. Hoshi. Functional near-infrared optical imaging: utility and limitations in human brain mapping. , 2003, Psychophysiology.
[17] A. Fallgatter,et al. Reduced frontal functional asymmetry in schizophrenia during a cued continuous performance test assessed with near-infrared spectroscopy. , 2000, Schizophrenia bulletin.
[18] Mitsutoshi Yamamoto,et al. A variant of the sigma receptor type-1 gene is a protective factor for Alzheimer disease. , 2005, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.
[19] H. Silver. Selective serotonin re-uptake inhibitor augmentation in the treatment of negative symptoms of schizophrenia , 2004, Expert opinion on pharmacotherapy.
[20] J. Hedreen,et al. Sigma receptors in post-mortem human brains. , 1988, The Journal of pharmacology and experimental therapeutics.
[21] J. Coyle,et al. The emerging role of glutamate in the pathophysiology and treatment of schizophrenia. , 2001, The American journal of psychiatry.
[22] Teruo Hayashi,et al. Understanding the molecular mechanism of sigma-1 receptors: towards a hypothesis that sigma-1 receptors are intracellular amplifiers for signal transduction. , 2003, Current medicinal chemistry.
[23] A. Prescott,et al. Small Molecule Antagonists of the σ-1 Receptor Cause Selective Release of the Death Program in Tumor and Self-Reliant Cells and Inhibit Tumor Growth in Vitro and in Vivo , 2004, Cancer Research.
[24] E. Kempner,et al. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[25] P. Várnai,et al. Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels , 2006, The Journal of cell biology.
[26] P. Goldman-Rakic,et al. D1 receptors in prefrontal cells and circuits , 2000, Brain Research Reviews.
[27] A. Zhang,et al. Sigma and PCP receptors in human frontal cortex membranes. , 1988, European journal of pharmacology.
[28] K. Kasai,et al. Estimation of premorbid IQ in individuals with Alzheimer’s disease using Japanese ideographic script (Kanji) compound words: Japanese version of National Adult Reading Test , 2006, Psychiatry and clinical neurosciences.
[29] U. Spampinato,et al. Intrastriatal administration of sigma ligands inhibits basal dopamine release in vivo , 2003, Neuropharmacology.
[30] John G. Csernansky,et al. Neural correlates of verbal and nonverbal working memory deficits in individuals with schizophrenia and their high-risk siblings , 2006, Schizophrenia Research.
[31] Teruo Hayashi,et al. σ-1 Receptor Ligands , 2004 .
[32] Masako Okamoto,et al. Three-dimensional probabilistic anatomical cranio-cerebral correlation via the international 10–20 system oriented for transcranial functional brain mapping , 2004, NeuroImage.
[33] T. Terao,et al. Polymorphisms of the σ1 receptor gene in schizophrenia: An association study , 2000 .
[34] K. Hashimoto. The NMDA Receptor Hypofunction Hypothesis for Schizophrenia and Glycine Modulatory Sites on the NMDA Receptors as Potential Therapeutic Drugs , 2006 .
[35] Teruo Hayashi,et al. Ca2+ Signaling via ς1-Receptors: Novel Regulatory Mechanism Affecting Intracellular Ca2+Concentration , 2000 .
[36] J. Henry,et al. A meta-analytic review of verbal fluency performance following focal cortical lesions. , 2004, Neuropsychology.
[37] H. Goldman,et al. Treatment outcomes in schizophrenia: implications for practice, policy, and research. , 1995, Schizophrenia bulletin.
[38] L. Werling,et al. ς1 Receptor Agonist-Mediated Regulation ofN-Methyl-d-aspartate-Stimulated [3H]Dopamine Release Is Dependent upon Protein Kinase C , 2003, Journal of Pharmacology and Experimental Therapeutics.
[39] Kiichi Ishiwata,et al. Sigma receptor ligands: possible application as therapeutic drugs and as radiopharmaceuticals. , 2006, Current pharmaceutical design.
[40] A. Akaike,et al. sigma receptor ligands attenuate N-methyl-D-aspartate cytotoxicity in dopaminergic neurons of mesencephalic slice cultures. , 2000, European journal of pharmacology.
[41] E. Portales-Casamar,et al. The antidepressant-like effect induced by the sigma1 (σ1) receptor agonist igmesine involves modulation of intracellular calcium mobilization , 2002, Psychopharmacology.
[42] David A. Boas,et al. A Quantitative Comparison of Simultaneous BOLD fMRI and NIRS Recordings during Functional Brain Activation , 2002, NeuroImage.
[43] M. Jackson,et al. An N‐terminal double‐arginine motif maintains type II membrane proteins in the endoplasmic reticulum. , 1994, The EMBO journal.
[44] Teruo Hayashi,et al. Sigma-1 Receptor Chaperones at the ER- Mitochondrion Interface Regulate Ca2+ Signaling and Cell Survival , 2007, Cell.
[45] T. Maurice,et al. Neuroprotective and anti-amnesic potentials of sigma (σ) receptor ligands , 1997, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[46] H. Suwaki,et al. Lack of association between sigma1 receptor gene variants and schizophrenia , 2004, Psychiatry and clinical neurosciences.
[47] S. Kay,et al. The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.
[48] K. Hashimoto,et al. High Occupancy of Sigma-1 Receptors in the Human Brain after Single Oral Administration of Fluvoxamine: A Positron Emission Tomography Study Using [11C]SA4503 , 2007, Biological Psychiatry.
[49] A. Villringer,et al. Beyond the Visible—Imaging the Human Brain with Light , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[50] T. Goldberg,et al. Letter and category fluency in schizophrenic patients: a meta-analysis , 2003, Schizophrenia Research.
[51] Yuko Fujita,et al. Phencyclidine-Induced Cognitive Deficits in Mice are Improved by Subsequent Subchronic Administration of Fluvoxamine: Role of Sigma-1 Receptors , 2007, Neuropsychopharmacology.
[52] Daniel R Weinberger,et al. Neuroimaging-genetic paradigms: a new approach to investigate the pathophysiology and treatment of cognitive deficits in schizophrenia. , 2006, Harvard review of psychiatry.
[53] August B. Hollingshead,et al. Two Factor Index of Social Position , 1957 .